Recent Updates
Recently added Catalysts
BHST Positive Sentiment Score: 70/100

MATERIAL CHANGE REPORT DATED MARCH 6, 2026 Material Change Report dated

Key Takeaway: BioHarvest Sciences Inc. reported a change in its board of directors, with David Tsur resigning and Prof. Hezi Levy appointed as his replacement. Prof. Levy brings extensive experience, having previously served as Director General of the Israeli Ministry of Health and led major health initiatives during the COVID-19 pandemic. His appointment is seen as a strategic move to bolster the company's leadership with robust healthcare expertise.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of Prof. Hezi Levy brings significant expertise.
  • Prof. Levy's experience includes leading Israel's healthcare system.
  • The change aims to enhance the board's effectiveness.

Full Press Release Details

MATERIAL CHANGE REPORT
Item 1.Name and Address of Company
BIOHARVEST SCIENCES INC.
Suite 1140 - 625 Howe Street
Vancouver, BC, V6C 2T6
(the "Company" or "BioHarvest")
Item 2.Date of Material Change
The news release was issued on March 5, 2026 and disseminated by Newsfile Corp.
Item 4.Summary of Material Change
The Company announced changes to it's board of directors.
Item 5.Full Description of Material Change
The Company announced the resignation of David Tsur as a director of the Company. Mr. Tsur served as a director since 2021. The Company also announced the immediate appointment of Prof. Hezi Levy to replace Mr. Tsur on its board of directors.
Prof. Levy joins the Board with decades of leadership experience across Israel's healthcare system. A physician by education, Prof. Levy previously served as Director General of the Israeli Ministry of Health, including during the COVID-19 pandemic, where he played a central role in guiding national healthcare policy. Prof. Levy also served as Head of the Medical Corps of the Israel Defense Forces (IDF) with the rank of Brigadier General and was the General Manager of Barzilai Medical Center for many years, overseeing one of Israel's major hospitals and complex healthcare operations.
Item 6.Reliance on Subsection 7.1(2) of National Instrument 51-102
Item 7.Omitted Information
Item 8.Executive Officer
For further information, please contact:
Secretary and VP, Investor Relations
Item 9.Date of Report

Frequently Asked Questions

What company announced a board of directors change?

BioHarvest Sciences Inc. announced changes to its board.

When was the material change announcement made?

The announcement was made on March 5, 2026.

Who resigned from BioHarvest's board?

David Tsur resigned as a director of BioHarvest.

Who replaced David Tsur on the board?

Prof. Hezi Levy was appointed to replace Mr. Tsur.

What is Prof. Hezi Levy's background?

He has extensive experience in Israel's healthcare system.

Last updated: Mar 6, 2026